Cetera Investment Advisers
HRTX icon

Cetera Investment Advisers’s Heron Therapeutics HRTX Stock Holding History

Cetera Investment Advisers’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2K Sell
13,991
-6
-0% -$7 ﹤0.01% 4689
2025
Q4 		$18.2K Hold
13,997
– – ﹤0.01% 4581
2025
Q3 		$17.6K Buy
13,997
+226
+2% +$358 ﹤0.01% 4497
2025
Q2 		$28.5K Buy
13,771
+1,520
+12% +$3.1K ﹤0.01% 4006
2025
Q1 		$27K Buy
12,251
+1,884
+18% +$3.66K ﹤0.01% 3899
2024
Q4 		$15.9K Sell
10,367
-4,889
-32% -$7.92K ﹤0.01% 3712
2024
Q3 		$30.4K Buy
15,256
+147
+1% +$351 ﹤0.01% 3631
2024
Q2 		$52.9K Buy
15,109
+1,602
+12% +$4.92K ﹤0.01% 3591
2024
Q1 		$37.4K Buy
+13,507
New +$34K ﹤0.01% 3593

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Cetera Investment Advisers's HRTX Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Heron Therapeutics (HRTX) stake by 0.04% in Q1 2026, selling an estimated $7 and leaving 13,991 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4689.

Cetera Investment Advisers first reported a position in HRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $52.9K in Q2 2024. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Cetera Investment Advisers held 13,991 shares of Heron Therapeutics worth $11.2K as of Q1 2026.
  • Cetera Investment Advisers sold 6 Heron Therapeutics shares in Q1 2026, an estimated $7.
  • Heron Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4689 holding.
  • Cetera Investment Advisers first reported a position in Heron Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Cetera Investment Advisers's Heron Therapeutics position peaked at $52.9K in Q2 2024.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.